Trade with Eva: Analytics in action >>
Showing posts with label IMPV. Show all posts
Showing posts with label IMPV. Show all posts

Wednesday, October 10, 2018

-=Imperva (IMPV) to be acquired by Thoma Bravo for $55.75/share

Imperva is a cyber security software and services company which provides protection to enterprise data and application software. 
Headquarters: Redwood Shores, California
Revenue: 321.7 million USD (2017)
Number of employees: 1,000
imperva.com

Imperva to be acquired by Thoma Bravo for $55.75/share in cash, or approximately $2.1 bln; deal includes go-shop period 
  • The transaction is currently expected to close late in the fourth quarter of 2018 or early in the first quarter of 2019, subject to approval by Imperva's stockholders and regulatory authorities and the satisfaction of customary closing conditions.
  • The merger agreement provides for a 45-day "go-shop" period, during which Imperva's Board and advisors may actively solicit alternative acquisition proposals and enter into negotiations with other parties. During this period, Imperva will have the right to terminate the merger agreement to enter into a superior proposal subject to the terms and conditions of the merger agreement. There can be no assurance this 45-day "go-shop" period will result in a superior proposal.
  • Prelim Q3 results: Co sees Non-GAAP EPS of $0.20-0.25 vs $0.14 S&P Capital IQ Consensus Estimate; revs $90-92 mln vs $87.97 mln S&P Capital IQ Consensus Estimate; billings of $103-105 mln

Thursday, November 10, 2011

Imperva raises $85.5m in NYSE IPO

The data protection solutions developer issued 4.75 million shares, at $18 per share, above its $14-16 target.



Data protection solutions developer Imperva Inc. raised a gross $85.5 million in its IPO on the New York Stock Exchange at a company value of $398 million. The company, founded by president and CEO Shlomo Kramer, issued 4.75 million shares, at $18 per share, above its $14-16 target. The shares will be traded under the symbol "IMPV".


In addition, shareholders sold 250,000 shares for a gross $4.5 million. If the underwriters exercise in full their over-allotment option to buy up to 750,000 shares, the offering will increase by a gross $13.5 million. The offering was based on the company's prospectus filed with the US Securities and Exchange Commission (SEC) yesterday.